Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Cash from Financing Activities
Abcellera Biologics Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Cash from Financing Activities
$10.4m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Cash from Financing Activities
CA$626.7k
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
15%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Cash from Financing Activities
CA$1.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
Innovotech Inc
XTSX:IOT
|
Cash from Financing Activities
-CA$60.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abcellera Biologics Inc's Cash from Financing Activities?
Cash from Financing Activities
10.4m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Cash from Financing Activities amounts to 10.4m USD.
What is Abcellera Biologics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-3%
The average annual Cash from Financing Activities growth rates for Abcellera Biologics Inc have been -75% over the past three years , -3% over the past five years .